REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

Clinics & ProvidersProvider Guide

IV Therapy Near You

Looking for iv therapy near you? This guide helps you understand what to look for in a peptide therapy provider, how to evaluate credentials and certifications, what questions to ask, and how to use Peptide Contacts's directory to compare options. Your safety starts with choosing the right provider.

Emerging Research

Based on emerging research. These findings are promising but require further validation.

What to Look For in a Provider

When searching for iv therapy near you, the quality of your provider matters as much as the treatment itself. Legitimate peptide therapy clinics should have licensed healthcare professionals on staff, established protocols based on published research, and transparent pricing.

Key credentials to verify include: state medical licensing, DEA registration where applicable, relationships with GMP-certified compounding pharmacies, and the use of third-party Certificate of Analysis (COA) testing for all compounds administered.

  • Licensed physician or nurse practitioner supervision
  • GMP-certified compounding pharmacy partnerships
  • Third-party COA testing on all peptide compounds
  • Transparent pricing with no hidden fees
  • Documented treatment protocols and follow-up care
  • Patient blood work and health screening requirements

Note: Always verify a provider's medical license through your state's licensing board before starting any peptide therapy program.

The Consultation Process

A reputable peptide therapy provider will require an initial consultation that includes a comprehensive health assessment, relevant blood work, and a discussion of your health goals. Be cautious of any clinic that prescribes peptides without proper medical evaluation.

During your consultation, expect questions about your medical history, current medications, allergies, and previous experience with peptide therapy. The provider should explain the proposed protocol, expected outcomes, potential side effects, and monitoring schedule.

  • Initial blood panel including CBC, metabolic panel, and hormone levels
  • Medical history review and contraindication screening
  • Customized protocol design based on individual health markers
  • Regular follow-up appointments and progress monitoring
  • Dosage adjustments based on response and lab results

Cost & Insurance Considerations

Peptide therapy costs vary significantly by provider, location, and specific protocol. Most peptide therapies are not covered by insurance, though some FDA-approved peptides (like semaglutide) may be covered under certain plans for approved indications.

Typical costs include: initial consultation ($150–$500), monthly peptide supply ($100–$500+ depending on compound), and follow-up labs ($100–$300). Compare total cost of care across providers, not just the peptide price, as some clinics bundle services differently.

Note: Be wary of prices that seem too good to be true. Extremely low pricing may indicate non-GMP sourcing or diluted compounds.

Find a Provider

Search our vendor directory for clinics and providers offering iv therapy near you protocols. Filter by location, certifications, and community reviews.

Clinics Near Columbus, Ohio

View All Providers

Want more detail?

Read the technical analysis

Frequently Asked Questions

How do I find a iv therapy near you provider near me?

Use Peptide Contacts's vendor directory to search for providers by location, certifications, and specialty. Key criteria to evaluate include medical licensing, GMP compounding pharmacy partnerships, COA testing practices, and community reviews. Filter results by your state or city for local options.

What should I expect during a peptide therapy consultation?

A quality provider will require blood work, a medical history review, and an in-person or telehealth consultation before prescribing any peptide therapy. Expect to discuss health goals, contraindications, and monitoring schedules. Be cautious of providers who prescribe without proper evaluation.

What is the regulatory status of peptides in 2026?

As of May 2026, the peptide regulatory landscape is in flux. RFK Jr. announced that 14 of 19 previously restricted Category 2 peptides are expected to return to Category 1 (legal to compound). FDA advisory committee meetings are scheduled for late July 2026. Formal reclassification has not yet been published. Check Peptide Contacts's regulatory tracker for live updates.

Does Peptide Contacts provide medical advice?

No. Peptide Contacts is a research intelligence platform. All content is for informational and educational purposes only. We do not recommend, prescribe, or endorse any peptide for human use. Content is sourced from published research and may not be complete or current. Always consult a licensed healthcare provider for medical decisions.

How often is IV Therapy Near You information updated?

Peptide Contacts continuously monitors published research, regulatory announcements, and vendor data. Pages are updated as new peer-reviewed studies are published or regulatory changes occur. Last reviewed: May 2026. Community members can also contribute corrections and updates through verified reviews.

Related Research Topics

Disclaimer: This page is for informational and research purposes only. Peptide Contacts does not provide medical advice, prescribe treatments, or endorse any substance for human use. Always consult a qualified healthcare professional before making any health-related decisions. Content is based on publicly available research as of 2026 and may not reflect the most current data.